PUM1
OFFICE ACTION ISSUED POU1
07/10/2026
Back to search
Official data from USPTO
STARSIDE DRUGS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
STARSIDE DRUGS
ST13
US500000088784048Class
35
Filing
88784048
Registration
6135569
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
17
Latest update
07/10/2026
Trademark type
Word
Nice classes
35
Filing date
02/04/2020
Registration date
08/25/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/25/2020
Last transaction
07/10/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
07/03/1991
First use in commerce
07/03/1991
Drawing code
4
Owner type
03
Owner location
Flushing, NY, US
Examiner
LAMONT, JOHN CHRISTOPHER
Law office
N50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
K&F Drug Corp
Representatives
K&F Drug Corp
Technical classification
Nice Classes
Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Administration of the business affairs of franchises; Compiling indexes of information; Mail order pharmacy services; On-line advertising services for others; On-line retail department store services; Retail drug store services; Online retail drug store services featuring in-store order pickup
Publications
History of USPTO decisions and trademark events.
17 publications found
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/10/2026
ES8R
TEAS SECTION 8 RECEIVED
06/03/2026
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/25/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
08/25/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/09/2020
PUBO
PUBLISHED FOR OPPOSITION
06/09/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/20/2020
ALIE
ASSIGNED TO LIE
05/04/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/24/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
04/24/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/24/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
04/24/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/24/2020
DOCK
ASSIGNED TO EXAMINER
04/23/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/07/2020
NWAP
NEW APPLICATION ENTERED
02/07/2020
Continuous trademark protection
Get notified about every new filing that threatens STARSIDE DRUGS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.